LIA.F LivaNova PLC

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
81.00 EUR
Close of Nov 13, 2026
45.60 82.50
Market cap
EUR 4.46B
P/E
27.0x
P/B
3.68x
ROE
16.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LIA.F undervalued?

Graham number
Price81.00
Graham value38.56
Premium110.1%

LIA.F trades 110.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LivaNova PLC fundamental analysis

No fundamental analysis for LivaNova PLC yet.

LivaNova PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LivaNova PLC

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VN…

Full company profile